DexCom, Inc. (NASDAQ:DXCM)

CAPS Rating: 1 out of 5

A medical device company focused on the design, development and commercialization of continuous glucose monitoring systems for people with diabetes.

Recs

7
Player Avatar BiLoandWise (25.51) Submitted: 5/4/2008 7:56:01 PM : Underperform Start Price: $7.28 DXCM Score: -404.46

Their devices haven't been selling, their financials are awful, the stock price has been plummeting and they're headed toward bankruptcy.

Featured Broker Partners


Advertisement